home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

InMode Ltd. - Ordinary Shares (NQ:INMD)

15.90 -0.72 (-4.33%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about InMode Ltd. - Ordinary Shares

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential ↗

March 02, 2023

There isn't much that's stopping them from penetrating their markets globally.

Via The Motley Fool

Target, InMode, Wynn Resorts And This US Bank Is A 'Favorite' In Financial Sector: CNBC's 'Final Trades' ↗

March 01, 2023

On CNBC’s "Halftime Report Final Trades," Karen Firestone of Aureus Asset Management said InMode Ltd. (NASDAQ: INMD) trades at 13 times next year's earnings.

Via Benzinga

2 High-Growth Stocks That Could Double Your Money in 5 Years or Less ↗

February 28, 2023

Both are likely to double quite soon, and they aren't even that risky.

Via The Motley Fool

Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023 ↗

February 28, 2023

Both have growth catalysts on the way, and plenty of recurring revenue too.

Via The Motley Fool

3 Under-the-Radar Growth Stocks with Promising Fundamentals ↗

February 23, 2023

Maximize your chances of success in the stock market by investing in these under-the-radar growth stocks that are trading at a discount.

Via InvestorPlace

InMode (INMD) Q4 2022 Earnings Call Transcript ↗

February 14, 2023

INMD earnings call for the period ending December 31, 2022.

Via The Motley Fool

InMode Slumps On Light Earnings Outlook Despite Quarterly Beat ↗

February 14, 2023

The company continued its trend of beating already strong quarterly expectations.

Via Investor's Business Daily

3 Reasons Wall Street Thinks InMode Can Rocket 47% Higher in 2023 ↗

January 27, 2023

Analysts' price targets for this stock suggest it could soon put up some big gains.

Via The Motley Fool

InMode Stock: Bull vs. Bear ↗

January 20, 2023

There are two sides of the coin with this healthcare stock.

Via The Motley Fool

Analyst Says M&A Could Be A Negative Catalyst For This Aesthetic Company ↗

February 17, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023 ↗

February 17, 2023

Via Benzinga

2 Terrific Growth Stocks to Buy With $200 Right Now ↗

February 16, 2023

You don't have to be rich to get your money to start working for you.

Via The Motley Fool

InMode Stock Dropped 9% Today ↗

January 11, 2023

Revenue in 2023 is expected to grow much slower than it has in recent years.

Via The Motley Fool

Better Medtech Stock to Buy: InMode or Outset Medical? ↗

February 15, 2023

Here are the "ins and outs" for these two stocks.

Via The Motley Fool

InMode's Q4 Earnings Surpass Expectations, Issues Mixed FY23 Guidance ↗

February 14, 2023

Via Benzinga

What's Going On With InMode Stock Today? ↗

February 14, 2023

InMode Ltd (NASDAQ: INMD) shares are trading lower Tuesday after the company reported better-than-expected results, but issued a weak earnings f

Via Benzinga

3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street ↗

February 12, 2023

Find out why the investment bankers who follow these stocks think they can soar in the near term.

Via The Motley Fool

3 No-Brainer Growth Stocks to Buy in 2023 ↗

February 03, 2023

These stocks all fell by double digits last year.

Via The Motley Fool

'I Think You Should Take The Money And Run': Cramer On This Stock Up 52% Over Past Month ↗

January 25, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Amicus Therapeutics Inc (NASDAQ: FOLD) is an "ideal spec.

Via Benzinga

Earnings Scheduled For February 14, 2023 ↗

February 14, 2023

Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.

Via Benzinga

2 Promising New Growth Stocks to Watch in 2023 ↗

January 23, 2023

These stocks have plenty of room to run.

Via The Motley Fool

InMode Stock Glowing Again As Cosmetic Surgery Market Recovers ↗

January 23, 2023

The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better.

Via Investor's Business Daily

3 Beaten-Down Growth Stocks That I'm Loading Up On in 2023 ↗

January 21, 2023

These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses.

Via The Motley Fool

Got $3,000? 3 Growth Stocks to Double Up On Right Now ↗

January 20, 2023

With these growth stocks down between 25% and 38% over the last year, it may be time to add to them as they widen their moats.

Via The Motley Fool

7 Must-Buy Nasdaq Stocks to Kick Off the First Quarter ↗

January 18, 2023

With the macro picture improving and growth stocks rebounding so far this year, investors should look for excellent Nasdaq stocks to buy.

Via InvestorPlace

3 Top Growth Stocks That Could Shoot 39% to 95% Higher in 2023 According to Wall Street ↗

January 18, 2023

Find out why the investment bank analysts who follow these stocks have such high hopes.

Via The Motley Fool

Buy Shares of This Supercharged Growth Stock Today to Beat the Market in 2023 ↗

January 16, 2023

InMode's growth is ramping up, and its valuation is on the cheap side, too.

Via The Motley Fool

3 Explosive Growth Stocks to Buy Now That Could Rocket Higher in 2023 ↗

January 14, 2023

The stock market can't ignore forever how quickly these businesses are growing.

Via The Motley Fool

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗

January 13, 2023

Sharp Tesla price cuts and some notable earnings were in focus.

Via Investor's Business Daily

More Likely to 5X First: CRISPR Therapeutics vs. InMode ↗

January 12, 2023

These two companies are in very different situations but could generate significant returns for investors.

Via The Motley Fool

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com